EGFR and glioblastoma: Our GBM model allows for cell-type specific tissue manipulation by expression of constitutively active forms of the RTK epidermal growth factor receptor (EGFR) and dp110, a subunit of PI3K, both of which are commonly mutated in human GBM tumors to drive tumorigenesis.